S100A1 and urinary bladder carcinoma: Together, these findings highlight that S100 proteins exhibit subtype- and stage-specific expression profiles in bladder cancer, which may serve as molecular correlates of tumor aggressiveness and potential biomarkers for patient stratification and therapeutic guidance.